Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults diagnosed with Acute Myeloid Leukemia (a type of blood cancer) whose cancer has come back after receiving a stem cell or bone marrow transplant from a donor (whether a family member or an unrelated donor), where the transplant could have used bone marrow, blood stem cells, or cord blood as the cell source, and who have signed the trial's consent form.
- People whose stored biological samples are held in a medical sample bank (biobank) and who previously gave permission for those samples to be stored and used — the specific consent form required may vary depending on which hospital or clinic is involved (confirm with trial site).
Who may not be able to join:
- People who are already enrolled in another clinical trial that has a rule preventing them from joining any additional studies at the same time.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fabio Ciceri, MD, IRCCS Ospedale San Raffaele
Phone: +39 02-2643-3093
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.